Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells.
about
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studiesβ2-Microglobulin-mediated signaling as a target for cancer therapyDecipher β2-microglobulin: gain- or loss-of-function (a mini-review)RANK-mediated signaling network and cancer metastasis.Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.Characterization of β2-microglobulin expression in different types of breast cancer.Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.Inhibition of β2-microglobulin/hemochromatosis enhances radiation sensitivity by induction of iron overload in prostate cancer cellsMicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cellsβ2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells.Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancerHooked on fat: the role of lipid synthesis in cancer metabolism and tumour development.RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.Lipids and prostate cancer.Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.Targeting the androgen receptor in prostate cancer.Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancerInduction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells.Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells.
P2860
Q26738585-4135CD2E-1048-4554-8743-46C45A9FC0EBQ26853735-C88FA389-4B23-4A0D-B9FB-80E995CD3D2DQ27023695-F2B3B198-84E9-4EB4-97A2-3ED1A6BCCE75Q30371052-4C2D558F-CC33-4EFF-96CE-E05DD4CA81E4Q33856101-0A1A0E4B-FE81-4302-A028-C191AE656716Q34340124-00F83788-3EF5-4488-98F7-03AEBBF0671CQ34586300-7B121E7A-BE2E-4328-9A87-C076B1C3B4D6Q34848208-F9800399-0786-4BC4-8B84-A5A4586A4938Q34948292-0B10B105-07DB-43EE-8535-A40E1AFA7E7AQ35237763-3220EC9B-5C89-4C3F-8AE2-F52C320DD70FQ35683332-B182837A-1229-44A2-9B01-126EC9F3B093Q36562253-8AEC706F-D0EE-46F8-A775-CCB0A7B8BC39Q37022317-A15941B9-1B79-47E4-A6A7-4D6061C32F77Q37287417-DBED15F2-A845-473E-8BD8-CC75433C0B02Q37648868-5EA0FFD0-2464-4F51-BFA3-8623F5AF63E7Q38002682-CDF545D6-80E7-4C0F-94F3-DD326A2F1B4DQ38029543-48A6C085-9F43-401E-86E3-2BFF2A76632EQ38217060-2B8AAEDE-C144-489B-9372-DE35B9ABE2CFQ38547110-2A7D1BEE-2C57-4B06-B9CF-F69BE01E1B17Q38948059-D81FAD97-773B-4328-BF64-8405835B2D81Q38958606-3EFB7B39-D2CA-4923-8086-8AE4DA18FFD8Q39285589-F9067A12-FB81-4C5C-8E75-6530D854F821Q39458787-0F776EF2-D310-4D2A-BB01-856F15477FD5Q46760444-D40048DB-00F9-46B3-929F-3299BF4525D9
P2860
Androgen receptor survival signaling is blocked by anti-beta2-microglobulin monoclonal antibody via a MAPK/lipogenic pathway in human prostate cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Androgen receptor survival sig ...... n human prostate cancer cells.
@ast
Androgen receptor survival sig ...... n human prostate cancer cells.
@en
type
label
Androgen receptor survival sig ...... n human prostate cancer cells.
@ast
Androgen receptor survival sig ...... n human prostate cancer cells.
@en
prefLabel
Androgen receptor survival sig ...... n human prostate cancer cells.
@ast
Androgen receptor survival sig ...... n human prostate cancer cells.
@en
P2093
P2860
P356
P1476
Androgen receptor survival sig ...... n human prostate cancer cells.
@en
P2093
Haiyen E Zhau
Leland W K Chung
Wen-Chin Huang
P2860
P304
P356
10.1074/JBC.M109.092759
P407
P577
2010-01-13T00:00:00Z